Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,031 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Incidence and prognostic value of tumour cells detected by RT-PCR in peripheral blood stem cell collections from patients with Ewing tumour.
Vermeulen J, Ballet S, Oberlin O, Peter M, Pierron G, Longavenne E, Laurence V, Kanold J, Chastagner P, Lejars O, Blay JY, Marec-Berard P, Michon J, Delattre O, Schleiermacher G. Vermeulen J, et al. Among authors: blay jy. Br J Cancer. 2006 Nov 20;95(10):1326-33. doi: 10.1038/sj.bjc.6603438. Epub 2006 Oct 31. Br J Cancer. 2006. PMID: 17088915 Free PMC article.
Prognosis and predictive value of KIT exon 11 deletion in GISTs.
Bachet JB, Hostein I, Le Cesne A, Brahimi S, Beauchet A, Tabone-Eglinger S, Subra F, Bui B, Duffaud F, Terrier P, Coindre JM, Blay JY, Emile JF. Bachet JB, et al. Among authors: blay jy. Br J Cancer. 2009 Jul 7;101(1):7-11. doi: 10.1038/sj.bjc.6605117. Epub 2009 Jun 16. Br J Cancer. 2009. PMID: 19536093 Free PMC article.
High frequency of beta-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management.
Dômont J, Salas S, Lacroix L, Brouste V, Saulnier P, Terrier P, Ranchère D, Neuville A, Leroux A, Guillou L, Sciot R, Collin F, Dufresne A, Blay JY, Le Cesne A, Coindre JM, Bonvalot S, Bénard J. Dômont J, et al. Among authors: blay jy. Br J Cancer. 2010 Mar 16;102(6):1032-6. doi: 10.1038/sj.bjc.6605557. Epub 2010 Mar 2. Br J Cancer. 2010. PMID: 20197769 Free PMC article.
Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG).
Garbay D, Le Cesne A, Penel N, Chevreau C, Marec-Berard P, Blay JY, Debled M, Isambert N, Thyss A, Bompas E, Collard O, Salas S, Coindre JM, Bui B, Italiano A. Garbay D, et al. Among authors: blay jy. Ann Oncol. 2012 Jan;23(1):182-186. doi: 10.1093/annonc/mdr051. Epub 2011 Mar 28. Ann Oncol. 2012. PMID: 21444357 Free article.
Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trials.
Cesne AL, Judson I, Maki R, Grosso F, Schuetze S, Mehren MV, Chawla SP, Demetri GD, Nieto A, Tanovic A, Blay JY. Cesne AL, et al. Among authors: blay jy. Br J Cancer. 2013 Oct 1;109(7):1717-24. doi: 10.1038/bjc.2013.524. Epub 2013 Sep 10. Br J Cancer. 2013. PMID: 24022187 Free PMC article. Clinical Trial.
Programmed cell death 1 (PD-1) targeting in patients with advanced osteosarcomas: results from the PEMBROSARC study.
Le Cesne A, Marec-Berard P, Blay JY, Gaspar N, Bertucci F, Penel N, Bompas E, Cousin S, Toulmonde M, Bessede A, Fridman WH, Sautes-Fridman C, Kind M, Le Loarer F, Pulido M, Italiano A. Le Cesne A, et al. Among authors: blay jy. Eur J Cancer. 2019 Sep;119:151-157. doi: 10.1016/j.ejca.2019.07.018. Epub 2019 Aug 21. Eur J Cancer. 2019. PMID: 31442817 Clinical Trial.
1,031 results